Pilot study shows impact of infection control staffing shortages on patient safety

Inadequate infection prevention and control staffing levels are associated with higher rates of healthcare-associated infections, according to a new study published today in the American Journal of Infection Control.

FDA Clears First Oral Device Treatment for Severe Sleep Apnea

The FDA cleared the first oral appliances for treating severe obstructive sleep apnea (OSA), Vivos Therapeutics announced on Wednesday. The removable complete airway repositioning and/or

December 1, 2023

No Aspirin After PCI? Extended P2Y12 Monotherapy? Trials Weigh In

AMSTERDAM — Two trials from Asia weighed in on reducing components and duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) but with

August 30, 2023

FDA formally pulls Oncopeptides’ cancer drug after prolonged back-and-forth

More than a year after the FDA called on Oncopeptides to withdraw Pepaxto (melphalan flufenamide), the Swedish company has finally lost its appeal, and the

February 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.